News

PRAC Meeting Highlights: Regulatory Updates from May 2026

PRAC · 2 min

ESMO 2025 Preview: Astra and Daiichi vs. Gilead

oncology · 3 min

Navigating the 2026 Cell Therapy Regulatory Landscape

FDA · cell therapy · 2 min

Merz Therapeutics and Kvvit Enter Exclusive Agreement for INBRIJA®

2 min

Tarsier Pharma IPO: NYSE Listings Expand with New Opportunities

2 min

Critical Medicines Act: EU Supply Security Push

2 min

EMA Management Board Meeting Highlights: March 2026 on Clinical Trials

EMA · 2 min

Imfinzi Approved for Unique Bladder Cancer Combo: A Game Changer

FDA · oncology · 2 min

Camizestrant Recommended for Approval in the EU for Advanced ER-Positive Breast Cancer

CHMP · breast cancer · 3 min

Hansa Licenses Idefirix to SERB for $133M: Implications for Investors

2 min

AI Accelerates Novo Nordisk's Parkinson’s Cell Therapy

cell therapy · 3 min

European Critical Medicines Act: Market Analysis and Implications

4 min